Hans Biomed Silcone Facial Implants
Based on innovative R&D technology
The company that creates newness never found anywhere else in the world
The sales of Hans Biomed Co. have grown around 25% for the last 5 years in a row, holding a stable financial position. In addition, we have 7 overseas subsidiaries and local branch offices around the world to expand business in the world. Starting R&D investment in new medical treatments and technology relate to regenerative medicine as well as tissue engineering, Hans Biomed has prepared itself for a new challenge for better health of humankind.
Registered to The U.S. Food and Drug Administration (FDA) in 2002
From the U.S.FDA that conducts field inspection on quality management, production facility, production lines, safety, etc. on regular basis, Biomed Co., Ltd. received
Selected as "World Top-Class Product Company
Selected as "World Top-Class Product Company" sponsored by the Ministry of Commerce, Industry and Energy in 2002 and 2010.
Hans Biomed Co.'s receiving the award (World Top-Class Product Company) implies that it was acknowledged as an excellent export-driven company, which was the first for a venture company that produces human tissue transplants.